Media Release: Federal Budget research funding welcomed by Rare Cancers Australia
May 16, 2024
Rare Cancers Australia (RCA) welcomed the Federal Government’s budget announcement this week,…
Read more arrow_forwardMedia Releases
Rare Cancers Australia (RCA) welcomed the Federal Government’s budget announcement this week,…
Read more arrow_forwardPeak cancer body, Rare Cancers Australia, has co-authored a pre-Budget submission of…
Read more arrow_forward
The peak body for rare cancers in Australia welcomes two new members…
Read more arrow_forwardOver the past two decades, our ability to rapidly obtain genomic information on an individual and their cancer has led to a dramatic shift in how we can diagnose, treat, monitor and prevent cancer, leading to an era of precision oncology.
Read more arrow_forwardRare Cancers Australia, and an army of peak cancer organisations, call on the Pharmaceutical Benefits Advisory Committee (PBAC) to expand access to the breakthrough PD-1/PD-L1 inhibitor class of medicines for the more than 3,500 Aussies who would benefit.
Read more arrow_forwardOver 650 people will be descending on Thredbo this week (15th & 16th March) to take on Australia’s highest peak, Mount Kosciuszko, in a charity challenge to raise awareness and vital funds for rare and less common cancers.
Read more arrow_forwardRare Cancers Australia has welcomed a recent approval by the TGA of the Novartis targeted therapy drug Tafinlar + Mekinist, which has proven to be effective in treating an extremely rare form of cancer mutation called BRAF 600E.
Read more arrow_forward
Rare Cancers Australia (RCA) has launched the country’s first comprehensive support guide dedicated to the unique challenges of a rare cancer experience.
Read more arrow_forward
On Tuesday 13th September 2022, leading charity Rare Cancers Australia (RCA) will launch a new online Thought Leader Series with some of the brightest minds in the Australian cancer community.
Read more arrow_forward
Rare Cancers Australia (RCA) welcomes the Government’s $61.2 million funding commitment announced today for Omico’s Project, PrOSPeCT.
Read more arrow_forward